The recommendation for Enflonsia is indicated for respiratory syncytial virus prevention in infants under eight months of age, expanding protection options ahead of the 2025–2026 season.

Sanofi acquires Vicebio for $1.15 billion, adding a next-gen RSV-hMPV vaccine and ‘Molecular Clamp' tech to strengthen its respiratory vaccine pipeline.

The new guidance on vaccines, such as those that protect against COVID-19, influenza, and RSV, will be released by the end of the summer, ahead of respiratory season.

About RSV Respiratory syncytial virus (RSV) is a contagious virus that causes widespread seasonal infections and can lead to serious respiratory conditions such as bronchiolitis and pneumonia.

A letter to the US public on the AMA website, signed by 75+ medical societies, stresses the vital importance of influenza, RSV, and COVID-19 vaccines.

Person dies from tick-borne virus in Bayfield County The patient was one of three Powassan virus cases reported in Wisconsin so far this year, all of which required hospitalization.

The flu, COVID-19, and RSV are distinct respiratory illnesses caused by different viruses, but they often present with overlapping symptoms, making it challenging to differentiate between them ...

Scientists warn of bat virus just one mutation from infecting humans Date: June 25, 2025 Source: Washington State University Summary: Viruses closely related to the deadly MERS coronavirus are ...

The order of planets from the sun: “And yes, I still include Pluto. I learned […] The post 21 Clever Mnemonic Devices That Will Help You Remember Almost Everything appeared first ...